MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,287,776 | +256.5% | 213,218 | +195.7% | 0.01% | +266.7% |
Q2 2023 | $2,605,154 | +4.0% | 72,105 | +7.0% | 0.00% | 0.0% |
Q1 2023 | $2,506,118 | +2.2% | 67,405 | +24.6% | 0.00% | 0.0% |
Q4 2022 | $2,451,498 | +12.5% | 54,105 | +73.8% | 0.00% | 0.0% |
Q3 2022 | $2,179,000 | +4.3% | 31,135 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $2,090,000 | -46.2% | 31,135 | -34.1% | 0.00% | -50.0% |
Q1 2022 | $3,884,000 | -58.0% | 47,235 | -25.1% | 0.00% | -50.0% |
Q4 2021 | $9,246,000 | -14.8% | 63,031 | +2.8% | 0.01% | -27.3% |
Q3 2021 | $10,850,000 | +18.4% | 61,331 | +7.1% | 0.01% | +22.2% |
Q2 2021 | $9,162,000 | +44.4% | 57,240 | +54.5% | 0.01% | +28.6% |
Q1 2021 | $6,347,000 | -18.2% | 37,054 | +4.8% | 0.01% | -22.2% |
Q4 2020 | $7,763,000 | +78.5% | 35,344 | +35.0% | 0.01% | +50.0% |
Q3 2020 | $4,349,000 | +51.2% | 26,190 | +4.0% | 0.01% | +50.0% |
Q2 2020 | $2,876,000 | +64.9% | 25,190 | +11.0% | 0.00% | +33.3% |
Q1 2020 | $1,744,000 | -52.5% | 22,690 | -20.3% | 0.00% | -40.0% |
Q4 2019 | $3,670,000 | +56.1% | 28,477 | -5.6% | 0.01% | +25.0% |
Q3 2019 | $2,351,000 | -16.7% | 30,177 | +10.1% | 0.00% | 0.0% |
Q2 2019 | $2,822,000 | +96.4% | 27,400 | +39.8% | 0.00% | +100.0% |
Q1 2019 | $1,437,000 | +114.5% | 19,600 | +24.1% | 0.00% | +100.0% |
Q4 2018 | $670,000 | -8.2% | 15,800 | +1.9% | 0.00% | 0.0% |
Q3 2018 | $730,000 | +80.7% | 15,500 | +89.0% | 0.00% | 0.0% |
Q2 2018 | $404,000 | +64.2% | 8,200 | +2.5% | 0.00% | – |
Q1 2018 | $246,000 | – | 8,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |